EligibleTrials

Vaping and Smoking Project in People With Schizophrenia

Recruiting · NCT06944847 · Interventional (participants receive a specific treatment) · Lead sponsor: State University of New York at Buffalo

View the official record on ClinicalTrials.gov →
Schizophrenia

Interventions studied

Acute (24-hour) abstinenceAd libitum smoking/vaping

What this trial is about

The proposed research will characterize withdrawal among people with schizophrenia who vape daily compared to people with schizophrenia who smoke combustible cigarettes daily, filling critical gaps in the understanding of electronic nicotine delivery systems (ENDS) dependence and contributing to the development of vaping cessation interventions amongst people with schizophrenia, the leading preventable cause of death in the US.

Who can take part

Age range
21 Years to 50 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.